The following post comes from Wade Cribbs, a 2L at Scalia Law and a Research Assistant at CPIP. By Wade Cribbs In patent law, equitable defenses can play an essential […]
[Archived Post] CPIP 2020 Fall Conference: Day Two Recap
The following post comes from Wade Cribbs, a 2L at Scalia Law and a Research Assistant at CPIP. This is the second of two posts (see day one recap) summarizing […]
[Archived Post] CPIP 2020 Fall Conference: Day One Recap
The following post comes from Terence Yen, a 4E at Scalia Law and a Research Assistant at CPIP. This is the first of two posts (see day two recap) summarizing […]
[Archived Post] Mark Schultz: Weaker Patent Protection Leads to Less Venture Capital Investment
The following post comes from David Ward, a 2L at Scalia Law and a Research Assistant at CPIP. By David Ward Venture capitalists pouring money into a small startup has […]
[Archived Post] New CPIP Policy Brief: The Long Shadow of the Blackberry Shutdown That Wasn’t
CPIP has published a new policy brief by CPIP Senior Fellow for Innovation Policy Jonathan Barnett entitled The Long Shadow of the Blackberry Shutdown That Wasn’t. The policy brief looks […]
[Archived Post] New Paper Looks at “Ill-Advised Legislative Proposals” to Address Pharmaceutical “Evergreening”
The following post comes from Yumi Oda, an LLM Candidate at Scalia Law and a Research Assistant at CPIP. By Yumi Oda Many believe that drug prices in the U.S. […]
[Archived Post] New Paper Explores Possibility of Gold-Plated Patents Beyond the PTAB’s Reach
What if there is a way for a patent applicant to obtain a “gold-plated patent” that is immune to administrative cancellation before the Patent Trial and Appeal Board (PTAB) at […]
[Archived Post] Supreme Court to Assess USPTO’s Controversial Attorneys’ Fees Position
By Chris Katopis & Devlin Hartline This week, the U.S. Supreme Court agreed to hear an important case concerning patent law procedures and the American legal system in general. In […]
[Archived Post] Recognizing the Limits of Government Procurement in the Pharmaceutical Industries
While recent headlines claim that rising drug prices can be easily addressed through government intervention, the procedures involved with government use of patented technologies are complex and often misunderstood. In […]
[Archived Post] CPIP Scholars Join Amicus Brief Arguing that the Government Cannot Petition for CBM Review
On December 17, 2018, CPIP Senior Scholars Adam Mossoff and Kristen Osenga joined an amicus brief written on behalf of seven law professors by Professor Adam MacLeod, a CPIP Thomas […]